Alto Ingredients has posted four consecutive profitable quarters, improved its balance sheet, and is rated Buy at $3.90 due to attractive forward valuation. Q2 2026 results were strong, driven by favorable ethanol markets, but future earnings depend on structural improvements like Section 45Z and Pekin plant expansion. Section 45Z credits could add ~$15M net profit in 2026, with further upside from lower carbon intensity and E15-driven demand growth from 2027 onward.